12 calendar weeks which brings us to mid-April in worst case scenario. This is assuming FDA hits their own timeline. I would expect they do here. They are more apt to move the date back on the final guidance as this is a new tech. FDA is super understaffed. Will be interesting to see timing in light of opiate issues plaguing the country.
News 
Market Data 
Discover 
